WESPAC Advisors LLC Grows Holdings in Procter & Gamble Company (The) $PG

WESPAC Advisors LLC grew its holdings in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 2.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,156 shares of the company’s stock after buying an additional 82 shares during the quarter. WESPAC Advisors LLC’s holdings in Procter & Gamble were worth $662,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC lifted its stake in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Nuveen LLC bought a new position in Procter & Gamble during the first quarter worth $1,954,941,000. Price T Rowe Associates Inc. MD lifted its stake in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Invesco Ltd. lifted its stake in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC lifted its stake in Procter & Gamble by 1,875.5% during the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after purchasing an additional 1,674,139 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Insider Activity at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 13,039 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the transaction, the chief operating officer directly owned 28,036 shares of the company’s stock, valued at approximately $4,409,221.72. This trade represents a 31.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider directly owned 182,422 shares in the company, valued at $28,689,507.94. This trade represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on PG. UBS Group set a $180.00 price objective on Procter & Gamble and gave the stock a “buy” rating in a research note on Wednesday, July 30th. BNP Paribas Exane dropped their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Berenberg Bank increased their target price on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research report on Wednesday, September 17th. Barclays dropped their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $173.11.

Get Our Latest Analysis on PG

Procter & Gamble Price Performance

Shares of PG opened at $152.60 on Wednesday. The firm has a market capitalization of $357.16 billion, a price-to-earnings ratio of 23.44, a price-to-earnings-growth ratio of 4.13 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43. The stock’s fifty day moving average is $155.30 and its 200-day moving average is $159.79.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same period last year, the company earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.